Drug intelligence / Profile preview

Fufang Pian

Development stage: Unknown
Lead developer: Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration: Oral

Overview

Fufang Pian is an investigational Traditional Chinese Medicine (TCM) compound tablet developed by the Longhua Hospital affiliated with the Shanghai University of Traditional Chinese Medicine. It is specifically formulated for the treatment of hemorrhoidal bleeding in patients diagnosed with the TCM syndromes of wind-heat blood stasis and damp-heat downward. As a "Fufang" (compound) preparation, it consists of a mixture of herbal extracts intended to clear heat, cool the blood, and resolve blood stasis to alleviate symptoms of internal or mixed hemorrhoids. The drug has been evaluated in Phase II clinical trials in China (e.g., CTR20180062) to assess its efficacy and safety in reducing rectal bleeding and improving clinical symptoms associated with hemorrhoids.

Other names: 复方片

Beyond the preview

Go deeper on Fufang Pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fufang Pian.

Explore the full profile